Can semaglutide cause microscopic haematuria or proteinuria?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 17, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Can Semaglutide Cause Microscopic Haematuria or Proteinuria?

Semaglutide does not typically cause microscopic haematuria, but it can be associated with proteinuria in rare cases, primarily through acute kidney injury mechanisms or rare podocytopathies rather than as a direct drug effect.

Proteinuria and Semaglutide

Expected Renal Effects

The FDA label and clinical trials demonstrate that semaglutide actually reduces albuminuria in most patients 1. In the SUSTAIN trials, semaglutide reduced urinary albumin-to-creatinine ratio (UACR) by 25-34% compared to placebo, with treatment ratios of 0.66-0.75 2. The FLOW trial showed a 24% reduction in major kidney disease events in patients with type 2 diabetes and CKD 3.

Paradoxical Proteinuria - Rare but Documented

Despite these protective effects, rare cases of new-onset proteinuria have been reported:

  • FDA Adverse Event Reporting System (FAERS) documented 17 cases of proteinuria associated with semaglutide 4
  • Acute interstitial nephritis (AIN) with proteinuria: Two biopsy-proven cases showed AIN, with one case demonstrating concurrent podocytopathy 4
  • Minimal change disease: A 2025 case report documented nephrotic-range proteinuria (nephrotic syndrome with foamy urine and edema) developing weeks after semaglutide initiation, with biopsy showing minimal change disease 5
  • Worsening proteinuria in pre-existing CKD: Two patients with diabetic kidney disease experienced increased proteinuria after starting semaglutide, with one showing interstitial lymphoplasmacytic and eosinophilic infiltrate on biopsy 6

Mechanism of Proteinuria

When proteinuria occurs with semaglutide, it appears related to:

  1. Acute kidney injury from volume depletion (gastrointestinal side effects causing dehydration)
  2. Immune-mediated injury (acute interstitial nephritis)
  3. Podocyte injury (rare podocytopathies)

Haematuria and Semaglutide

There is no documented association between semaglutide and microscopic haematuria in the FDA label 1, clinical guidelines 7, 3, or published case reports 4, 6, 5. The FAERS database contains no reports of haematuria with semaglutide 4.

Clinical Algorithm for Monitoring

Before Starting Semaglutide

  • Baseline urinalysis with microscopy
  • Baseline UACR or urine protein-to-creatinine ratio
  • Baseline serum creatinine and eGFR

During Treatment

Monitor kidney function if:

  • Significant gastrointestinal symptoms develop (nausea, vomiting, diarrhea)
  • Patient has moderate-to-severe CKD (eGFR <45 mL/min/1.73 m²)
  • New lower extremity edema or foamy urine appears

If new proteinuria develops:

  1. Immediately assess volume status - check for dehydration from GI side effects
  2. Measure serum creatinine - look for acute kidney injury
  3. Quantify proteinuria - obtain UACR or 24-hour urine protein
  4. If nephrotic-range proteinuria (>3.5 g/day) or AKI develops: Discontinue semaglutide and refer to nephrology for potential biopsy
  5. If mild proteinuria without AKI: Ensure adequate hydration, recheck in 2-4 weeks

Key Pitfalls to Avoid

  • Do not assume all proteinuria with semaglutide is drug-related - most patients experience reduced albuminuria 2
  • Do not ignore GI symptoms - most kidney adverse events occur in patients with significant nausea, vomiting, or diarrhea causing volume depletion 6
  • Do not continue semaglutide if acute worsening of kidney function occurs - the medication should be stopped immediately 6
  • Do not use semaglutide without caution in moderate-to-severe CKD - limited kidney reserve increases vulnerability to adverse events 6

Bottom Line

While semaglutide demonstrates renal protective effects in most patients, rare cases of proteinuria can occur through immune-mediated kidney injury or podocytopathies. Haematuria is not an established adverse effect. The overall renal benefits (reduced albuminuria, slowed CKD progression) far outweigh these rare risks in appropriately selected patients 7, 3, 2, 8. However, vigilance for new proteinuria or kidney dysfunction is warranted, particularly in patients experiencing significant gastrointestinal side effects.

References

4
Research

Semaglutide-associated kidney injury.

Clinical kidney journal, 2024

Related Questions

What is the relationship between semaglutide (GLP-1 receptor agonist) and dark urine, a potential indicator of impaired renal function or hepatic dysfunction?
In a 16-year-old taking semaglutide who has approximately 30 mg/dL protein on urine dipstick, how should this proteinuria be evaluated and managed?
Are kidney stones a contraindication to Ozempic (semaglutide)?
What alternative treatment options are available for a patient with type 2 diabetes and impaired renal function who experienced vision changes while on Ozempic (semaglutide)?
In a patient with a history of pancreatitis, low ejection fraction, hypotension, and moderate chronic kidney disease (estimated glomerular filtration rate ≈45 mL/min/1.73 m²), is Ozempic (semaglutide) contraindicated?
Should prophylactic antibiotics be given for a colovesical fistula?
What is another name for quetiapine?
In a patient taking oral minoxidil 1.25 mg daily, how long does it take to see new hair growth and increased hair density?
After taking codeine, how long should I wait before driving or operating machinery?
Can turmeric (curcumin) be used as an adjunct therapy for fatty liver disease, and what dosage, duration, and safety precautions should be considered?
What are the typical skin conditions in a newborn and their appropriate management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.